| pubmed-article:8723190 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0023779 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0065058 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
| pubmed-article:8723190 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
| pubmed-article:8723190 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8723190 | pubmed:dateCreated | 1996-9-20 | lld:pubmed |
| pubmed-article:8723190 | pubmed:abstractText | Fasting plasma cholesterol, triglycerides, high-density lipoprotein (HDL) and apoprotein (apo) B were elevated in 214 nondiabetic renal transplant recipients when compared to a reference group. Apo (a) was slightly but not significantly lower in transplant recipients (median 118 mg/dl, range 16-1680 vs 130 mg/dl, 10-1176) and this difference could be predicted from Lp (a) isoform analysis. Cholesterol, triglyceride, apo B and apo (a) concentrations correlated negatively with creatinine clearance but none of these parameters showed a significant association with proteinuria. Patients treated with steroids had higher plasma HDL concentrations than those receiving cyclosporin monotherapy (P < 0.01). The use of diuretics was associated with raised triglycerides (P < 0.001) and cholesterol (P < 0.01) and with reduced HDL (P < 0.01) whilst patients receiving beta-blockers had significantly higher triglycerides (P < 0.01) and lower HDL levels (P < 0.02). In multiple regression analysis, age (P < 0.01), creatinine clearance (P < 0.05) and diuretic therapy (P < 0.005) were independent risk factors for increased cholesterol whilst apo (a) levels correlated negatively with creatinine clearance (P < 0.005). These results suggest that impaired renal function, steroids and non-immunosuppressive drugs contribute to lipid abnormalites in renal transplant recipients. | lld:pubmed |
| pubmed-article:8723190 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8723190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8723190 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8723190 | pubmed:issn | 0934-0874 | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:MorganRR | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:SeedMM | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:ReesAA | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:MooreR HRH | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:ThomasD MDM | lld:pubmed |
| pubmed-article:8723190 | pubmed:author | pubmed-author:WheelerD CDC | lld:pubmed |
| pubmed-article:8723190 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8723190 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:8723190 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8723190 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8723190 | pubmed:pagination | 221-6 | lld:pubmed |
| pubmed-article:8723190 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:meshHeading | pubmed-meshheading:8723190-... | lld:pubmed |
| pubmed-article:8723190 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8723190 | pubmed:articleTitle | Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients. | lld:pubmed |
| pubmed-article:8723190 | pubmed:affiliation | Renal Transplant Unit, Cardiff Royal Infirmary, Wales, UK. | lld:pubmed |
| pubmed-article:8723190 | pubmed:publicationType | Journal Article | lld:pubmed |
